Advertisement

ST-Elevation Myocardial Infarction

  • Eric R. BatesEmail author
  • Brahmajee K. Nallamothu
Chapter
Part of the Contemporary Cardiology book series (CONCARD)

Abstract

Acute ST-elevation myocardial infarction (STEMI) is the leading cause of death in the United States. The American Heart Association estimated that there were 750,000 Americans with acute myocardial infarction (MI) in 2016 (American Heart Association, Circulation 133:e38–e360, 2016). Approximately 30–45% of these were STEMI. Excellent societal guideline recommendations exist for STEMI care (O’Gara et al, J Am Coll Cardiol 61:e78–e140, 2013; Levine et al, J Am Coll Cardiol 67:1235–1250, 2016; Steg et al, Eur Heart J 33:2569–2619, 2012).

Keywords

Atherosclerotic plaque Electrocardiogram Myocardial infarction Thrombosis Troponin 

References

  1. 1.
    American Heart Association. Heart disease and stroke statistics – 2016 update. A report from the American Heart Association. Circulation. 2016;133:e38–e360.Google Scholar
  2. 2.
    O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61:e78–140.CrossRefGoogle Scholar
  3. 3.
    Levine GN, Bates ER, Blankenship JC, et al. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. J Am Coll Cardiol. 2016;67:1235–50.CrossRefGoogle Scholar
  4. 4.
    Steg PG, James SK, Atar D, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33:2569–619.CrossRefGoogle Scholar
  5. 5.
    Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60:1581–98.CrossRefGoogle Scholar
  6. 6.
    Kushner FG, Bates ER. ST-elevation myocardial infarction. In: Antman E, editor. Cardiovascular therapeutics, a companion to Braunwald’s heart disease. 4th ed. Philadelphia: Elsevier Saunders; 2012. p. 178–213.Google Scholar
  7. 7.
    Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;136:13–20.CrossRefGoogle Scholar
  8. 8.
    Wijeysundera HC, Vijayaraghavan R, Nallamothu BK, et al. Rescue angioplasty or repeat fibrinolysis after failed fibrinolytic therapy for ST-segment myocardial infarction: a meta-analysis of randomized trials. J Am Coll Cardiol. 2007;49:422–30.CrossRefGoogle Scholar
  9. 9.
    Keeley EC, Boura JA, Grines CL. Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials. Lancet. 2006;367:579–88.CrossRefGoogle Scholar
  10. 10.
    Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005;352:1179–89.CrossRefGoogle Scholar
  11. 11.
    Stone GW, Witzenbichler B, Guagliumi G, et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med. 2008;358:2218–30.CrossRefGoogle Scholar
  12. 12.
    Yusuf S, Mehta SR, Chrolavicius S, et al. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. JAMA. 2006;295:1519–30.CrossRefGoogle Scholar
  13. 13.
    Antman EM, Morrow DA, McCabe CH, et al. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med. 2006;354:1477–88.CrossRefGoogle Scholar
  14. 14.
    Eikelboom JW, Quinlan DJ, Mehta SR, Turpie AG, Menown IB, Yusuf S. Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials. Circulation. 2005;112:3855–67.CrossRefGoogle Scholar
  15. 15.
    Krumholz HM, Anderson JL, Bachelder BL, et al. ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to develop performance measures for ST-elevation and non-ST-elevation myocardial infarction). Circulation. 2008;118:2596–648.CrossRefGoogle Scholar
  16. 16.
    Ryan TJ, Anderson JL, Antman EM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 1996;28:1328–428.CrossRefGoogle Scholar
  17. 17.
    Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, Giugliano RP, McCabe CH, Braunwald E. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy. Circulation. 2000;102:2031–7.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Division of Cardiovascular MedicineUniversity of Michigan Medical CenterAnn ArborUSA

Personalised recommendations